Piper Jaffray Raises Price Target on Abiomed (ABMD) Following 1Q16

Go back to Piper Jaffray Raises Price Target on Abiomed (ABMD) Following 1Q16

Notable 52-Week Highs and Lows 8/4: (NFLX) (SABR) (VMC) High; (NRG) (TNET) (CNX) Low

August 4, 2015 3:12 PM EDT

52-Week High:Netflix (Nasdaq: NFLX) $122.78. Netflix getting another boost today as Guggenheim started coverage on the stock with a Buy rating and a price target of $160. Analyst Michael Morris summarized: Netflix is the clear industry leader in what we believe is still the early stage of a massive global shift to Internet TV delivery. We expect global subscriber growth to remain strong, fueled by an expanding original content lineup and additional international market launches. Our forecast calls for a... More

Abiomed (ABMD) Tops Q1 EPS by 12c

August 4, 2015 7:03 AM EDT

Abiomed (NASDAQ: ABMD) reported Q1 EPS of $0.20, $0.12 better than the analyst estimate of $0.08. Revenue for the quarter came in at $73.4 million versus the consensus estimate of $66.27 million.

Abiomed sees FY2015 revenue of $300-310 million, versus prior guidance of $285-295 million and the consensus of $292.4... More

Trading Radar for 8/4: Zillow (Z), Archer Daniels (ADM), Hyatt Hotels (H), Kellogg (K), Sprint (S), Mosaic (MOS) Report

August 3, 2015 3:16 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

A.M. Castle & Co. (NYSE: CAS) - consensus loss $0.48
ALLETE, Inc. (NYSE: ALE) - consensus EPS $0.50
ANI Pharma (Nasdaq: ANIP) - consensus EPS $0.54
Abiomed (Nasdaq: ABMD) - consensus EPS $0.08
Aetna (NYSE: AET) - consensus EPS $1.82
Affimed (Nasdaq: AFMD) - consensus loss $0.17
Albany... More